Last reviewed · How we verify
NCT07123389
Family and Peer Influences on Nicotine Dependence in Medical Students of South Punjab
trial in Nicotine Dependence in 366 participants. Completed in 15 July 2025.
2 July 2025
Quick facts
| Lead sponsor | Nishtar Medical University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 366 |
| Start date | 13 May 2025 |
| Primary completion | 2 July 2025 |
| Estimated completion | 15 July 2025 |
| Sites | 1 location across Pakistan |
Conditions studied
- Nicotine Dependence — all drugs for Nicotine Dependence →
- Tobacco Use Disorder — all drugs for Tobacco Use Disorder →
- Family Functioning — all drugs for Family Functioning →
- Peer Influence — all drugs for Peer Influence →
Sponsor
Nishtar Medical University
Who can join
18 and older, any sex, with Nicotine Dependence or Tobacco Use Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this cross-sectional observational study is to assess the impact of family functioning and peer pressure on nicotine dependence in medical students enrolled at medical colleges in South Punjab, Pakistan (both male and female; aged 18 and older). The main questions it aims to answer are: Does family dysfunction contribute to higher nicotine dependence in medical students? Does peer pressure intensify the effect of family dysfunction on nicotine dependence? Are there gender or academic year differences in smoking status and peer pressure? If there is a comparison group: Researchers will compare students from functional families vs. dysfunctional families to see if nicotine dependence differs, especially under the influence of peer pressure. Participants will: Complete a structured, self-administered questionnaire which includes: The Fagerstrom Test for Nicotine Dependence (FTND) to assess nicotine addiction severity. The Family Assessment Device-General Functioning (FAD-GF) to evaluate family functioning. The Peer Pressure Scale to identify direct and indirect peer pressure. Provide demographic information (age, gender, year of study, smoking status) for descriptive and comparative analyses.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07123389
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Nicotine Dependence
Currently open trials in the same condition.
- NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
- NCT07250230 — Effect of Perioperative High-dose Transdermal Nicotine Patch on Pain Sensitivity Among Male Abstinent Tobacco Smokers Un · NA · recruiting
- NCT07040566 — A Trial of Varenicline for E-cigarette Cessation · Phase 2 · recruiting
- NCT07001930 — Effects of Cannabidiol on Stress and Nicotine Withdrawal · Phase 1 · recruiting
- NCT06765291 — Behavioral Intervention for Youth to Promote Vaping Cessation · NA · recruiting
Other Nishtar Medical University trials
Trials by the same sponsor.
- NCT07208799 — Comparison of Submucosal Dexamethasone and Methylprednisolone in Postoperative Sequelae of Parasymphsis Fractures · Phase 2 · recruiting
- NCT07537842 — Comparison of Finnish and Viennese Techniques for Perineal Protection in Women During the Second Stage of Labor · NA · completed
- NCT07288801 — Vitamin D for Preventing Recurrent Preeclampsia in Pregnant Women · Phase 4 · recruiting
- NCT07466342 — Vitamin E Plus Mefenamic Acid Versus Mefenamic Acid Alone for Treating Primary Dysmenorrhea in Women · Phase 4 · completed
- NCT07503184 — Intravenous Dexamethasone for Inducing Labor in Women With Term Pregnancy and Pre-Labour Rupture of Membranes · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07123389 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nishtar Medical University
- Last refreshed: 14 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07123389.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing